(Q43280139)

18 November 2017

Delay to formalin fixation effect on breast biomarkers (English)

1 reference

18 November 2017

0 references

Thaer Khoury

1

1 reference

18 November 2017

Sheila Sait

2

1 reference

18 November 2017

Helena Hwang

3

1 reference

18 November 2017

Rameela Chandrasekhar

4

1 reference

18 November 2017

Gregory Wilding

5

1 reference

18 November 2017

Dongfeng Tan

6

1 reference

18 November 2017

Swati Kulkarni

7

1 reference

18 November 2017

4 September 2009

1 reference

18 November 2017

1 reference

18 November 2017

22

1 reference

18 November 2017

11

1 reference

18 November 2017

1457-1467

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.117

18 November 2017

0 references

cites work

Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

Clinical Experience with Trastuzumab (Herceptin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

Lability of steroid hormone receptors following devascularization of breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

Effect of formalin tissue fixation and processing on immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Bre

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

Effect of fixation period on HER2/neu gene amplification detected by fluorescence in situ hybridization in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

HER2 status and benefit from adjuvant trastuzumab in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

Sampling Procedures in Estrogen Receptor Determinations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

Comparison of estrogen receptor levels in breast cancer samples from mastectomy and frozen section specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

Discrepancy in ER levels of breast carcinoma in biopsy vs mastectomy specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

On the chemistry of formaldehyde fixation and its effects on immunohistochemical reactions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

Preservation of cluster 1 small cell lung cancer antigen in zinc-formalin fixative and its application to immunohistological diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

Fluorescence in situ hybridization on formalin-fixed and paraffin-embedded tissue: optimizing the method

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.117

7 January 2021

10.1038/MODPATHOL.2009.117

Identifiers

DOI

1 reference

Dimensions Publication ID

18 November 2017

0 references

1 reference